Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2

M. Visentini; L. Gragnani; Stefano Angelo Santini; T. Urraro; A. Villa; M. Monti; A. Palladino; L. Petraccia; Gualana F. La; S. Lorini; S. Marri; F. Madia; L. Stefanini; S. Basili; M. Fiorilli; C. Ferri; A. L. Zignego; M. Casato

doi:10.1136/annrheumdis-2021-221248

Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2

M. Visentini^*, L. Gragnani, Stefano Angelo Santini, T. Urraro, A. Villa, M. Monti, A. Palladino, L. Petraccia, Gualana F. La, S. Lorini, S. Marri, F. Madia, L. Stefanini, S. Basili, M. Fiorilli, C. Ferri, A. L. Zignego, M. Casato

^*Autore corrispondente per questo lavoro

Facoltà di Medicina e Chirurgia "A.Gemelli"

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

Studies on the safety and immunogenicity of SARS-CoV-\r\n2\r\nvaccination in patients with inflammatory rheumatic diseases\r\nhave so far not included mixed cryoglobulinaemia (MC)\r\nvasculitis.1–3 We report a prospective observational multicentre\r\nstudy on this disorder.

Lingua originale	Inglese
pagine (da-a)	441-443
Numero di pagine	3
Rivista	Annals of the Rheumatic Diseases
Volume	81
Numero di pubblicazione	3
DOI	https://doi.org/10.1136/annrheumdis-2021-221248
Stato di pubblicazione	Pubblicato - 2022

All Science Journal Classification (ASJC) codes

Reumatologia
Immunologia e Allergia
Immunologia
Biochimica, Genetica, Biologia Molecolare Generali

Keywords

COVID-19
systemic vasculitis
vaccination

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1136/annrheumdis-2021-221248

Altri file e collegamenti

Cita questo

Visentini, M., Gragnani, L., Santini, S. A., Urraro, T., Villa, A., Monti, M., Palladino, A., Petraccia, L., La, G. F., Lorini, S., Marri, S., Madia, F., Stefanini, L., Basili, S., Fiorilli, M., Ferri, C., Zignego, A. L., & Casato, M. (2022). Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2. Annals of the Rheumatic Diseases, 81(3), 441-443. https://doi.org/10.1136/annrheumdis-2021-221248

@article{cf672aa045384d8eb21dbe8eeef47e03,

title = "Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2",

abstract = "Studies on the safety and immunogenicity of SARS-CoV-\textbackslash{}r\textbackslash{}n2\textbackslash{}r\textbackslash{}nvaccination in patients with inflammatory rheumatic diseases\textbackslash{}r\textbackslash{}nhave so far not included mixed cryoglobulinaemia (MC)\textbackslash{}r\textbackslash{}nvasculitis.1–3 We report a prospective observational multicentre\textbackslash{}r\textbackslash{}nstudy on this disorder.",

keywords = "COVID-19, systemic vasculitis, vaccination, COVID-19, systemic vasculitis, vaccination",

author = "M. Visentini and L. Gragnani and Santini, \{Stefano Angelo\} and T. Urraro and A. Villa and M. Monti and A. Palladino and L. Petraccia and La, \{Gualana F.\} and S. Lorini and S. Marri and F. Madia and L. Stefanini and S. Basili and M. Fiorilli and C. Ferri and Zignego, \{A. L.\} and M. Casato",

year = "2022",

doi = "10.1136/annrheumdis-2021-221248",

language = "English",

volume = "81",

pages = "441--443",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "London, United Kingdom: BMJ / British Medical Journal Publishing Group",

number = "3",

}

Visentini, M, Gragnani, L, Santini, SA, Urraro, T, Villa, A, Monti, M, Palladino, A, Petraccia, L, La, GF, Lorini, S, Marri, S, Madia, F, Stefanini, L, Basili, S, Fiorilli, M, Ferri, C, Zignego, AL & Casato, M 2022, 'Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2', Annals of the Rheumatic Diseases, vol. 81, n. 3, pagg. 441-443. https://doi.org/10.1136/annrheumdis-2021-221248

TY - JOUR

T1 - Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2

AU - Visentini, M.

AU - Gragnani, L.

AU - Santini, Stefano Angelo

AU - Urraro, T.

AU - Villa, A.

AU - Monti, M.

AU - Palladino, A.

AU - Petraccia, L.

AU - La, Gualana F.

AU - Lorini, S.

AU - Marri, S.

AU - Madia, F.

AU - Stefanini, L.

AU - Basili, S.

AU - Fiorilli, M.

AU - Ferri, C.

AU - Zignego, A. L.

AU - Casato, M.

PY - 2022

Y1 - 2022

N2 - Studies on the safety and immunogenicity of SARS-CoV-\r\n2\r\nvaccination in patients with inflammatory rheumatic diseases\r\nhave so far not included mixed cryoglobulinaemia (MC)\r\nvasculitis.1–3 We report a prospective observational multicentre\r\nstudy on this disorder.

AB - Studies on the safety and immunogenicity of SARS-CoV-\r\n2\r\nvaccination in patients with inflammatory rheumatic diseases\r\nhave so far not included mixed cryoglobulinaemia (MC)\r\nvasculitis.1–3 We report a prospective observational multicentre\r\nstudy on this disorder.

KW - COVID-19

KW - systemic vasculitis

KW - vaccination

KW - COVID-19

KW - systemic vasculitis

KW - vaccination

UR - https://publicatt.unicatt.it/handle/10807/238936

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85124633723&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85124633723&origin=inward

U2 - 10.1136/annrheumdis-2021-221248

DO - 10.1136/annrheumdis-2021-221248

M3 - Article

SN - 0003-4967

VL - 81

SP - 441

EP - 443

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - 3

ER -

Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2

Abstract

All Science Journal Classification (ASJC) codes

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo